GAIN THERAPEUTICS, INC Shareholders' Equity
GAIN THERAPEUTICS, INC (GANX) had Shareholders' Equity of $11.29 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $11.29M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $14.01M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $18.56M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.91M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $11.29M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $14.01M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $18.56M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $5.91M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.70M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $5.78M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $7.34M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $8.91M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $11.78M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $8.64M 10-Q · filed 2025-08-12 |
| 2023-12-31 | $12.58M 10-K · filed 2026-03-26 |
| 2023-09-30 | $7.33M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $11.09M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $15.14M 10-Q · filed 2024-08-08 |
| 2022-12-31 | $18.88M 10-K · filed 2025-03-27 |
| 2022-09-30 | $22.66M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $27.02M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $31.83M 10-Q · filed 2023-08-10 |
| 2021-12-31 | $34.82M 10-K · filed 2024-03-26 |
| 2021-09-30 | $37.55M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $41.39M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $44.46M 10-Q · filed 2022-08-08 |
| 2020-12-31 | $6.20M 10-K · filed 2023-03-23 |
| 2020-09-30 | $7.83M 10-Q · filed 2021-11-12 |
| 2020-06-30 | -$476.59K 10-Q · filed 2021-11-12 |
| 2020-03-31 | $70.40K 10-Q · filed 2021-08-12 |
| 2019-12-31 | -$449.86K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |